Incorporated in December 2017, Senores Pharmaceuticals Limited develops and manufactures a range of pharmaceutical products primarily for the regulated markets of the US, Canada, and the UK, while also serving emerging markets.
The company’s product portfolio consists of Amphetamine Sulfate Tablets, Hydroxychloroquine Sulfate Tablets, Ketoconazole Tablets, Butalbital, Acetaminophen and Caffeine Capsules, Mexiletine Hydrochloride Capsules, Ketorolac Tromethamine Tablets, Diclofenac Potassium Tablets, Diclofenac Potassium Tablets, Nicardipine Hydrochloride Capsules, Escitalopram Tablets, Prochlorperazine Maleate Tablets USP, Terazosin Capsules USP, Morphine Sulfate Tablets, Methadone Hydrochloride Tablets, Cyclobenzaprine Hydrochloride Tablets, Irbesartan Tablets, Risperidone Tablets Topiramate Capsules, and Ivermectin Tablets for regulated markets.
As of September 30, 2024, the company has launched 55 products in key therapeutic areas, including antibiotics and anti-fungal treatments. They have established partnerships with distributors and hospitals across several states in India.
As of September 30, 2024, the company operates three dedicated R&D facilities in India and the US.
The company operates in Emerging Markets across 43 countries and manufactures critical care injectables and APIs.
The company’s manufacturing unit is situated in Ahmedabad, Gujrat.
Competitive Strength
Senores Pharmaceuticals Limited’s revenue increased by 457% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 678.08 | 621.88 | 131.05 | 59.15 | ||||||||||||||||||||||||||||||||||||
| Revenue | 183.35 | 217.34 | 39.02 | 14.63 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 23.94 | 32.71 | 8.43 | 0.99 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 319.06 | 231.71 | 45.5 | 36.59 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 263.36 | 175.94 | 35.25 | 25.37 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 242.03 | 248.38 | 60.76 | 14.21 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
The market capitalization of Senores Pharmaceuticals IPO is Rs 1350.70 Cr.
KPI as of Sun, Mar 31, 2024.
| KPI | Values |
|---|---|
| ROE | 23.60% |
| ROCE | 11.73% |
| Debt/Equity | 1.07 |
| RoNW | 23.60% |
| PAT Margin | 15.25 |
| Price to Book Value | 5.84 |
The Company proposes to utilise the Net Proceeds towards funding the following objects:
| IPO Date | December 20, 2024 to December 24, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹372 to ₹391 per share |
| Lot Size | 38 Shares |
| Total Issue Size | 1,48,87,723 shares (aggregating up to ₹582.11 Cr) |
| Fresh Issue | 1,27,87,723 shares (aggregating up to ₹ 500.00 Cr) |
| Offer for Sale | 21,00,000 shares of ₹10 (aggregating up to ₹82.11 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 3,32,65,865 shares |
| Share Holding Post Issue | 4,60,53,588 shares |
The promoters of the company are Swapnil Jatinbhai Shah and Ashokkumar Vijaysinh Barot.
| Share Holding Pre Issue | 71.10% |
| Share Holding Post Issue |
Looking to invest ethically or according to Islamic principles? Expert Ethical brokers can help. Whether you need an ethical investment broker, a halal stock broker in India, or a Shariah-compliant broker, there are specialists available. Discover how to align your investments with your values and start your journey towards ethical wealth creation today through Ethical IAP or Ethical PMS.
Visit Prosperia.in to learn more about Ethical Investment Opportunities and start your journey towards ethical wealth creation today.
As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in
The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.
Last Updated on December 23, 2024 Unimech Aerospace and Manufacturing Ltd ipo Incorporated in 2016, Unitech Aerospace and Manufacturing Limited is engaging in the manufacturing of complex tools like mechanical
Last Updated on December 19, 2024 Carraro India Limited IPO Incorporated in 1997, Carraro India Ltd is engaging in manufacturing components ranging from the smallest gear to complete tractor manufacturing.
Last Updated on December 18, 2024 Senores Pharmaceuticals Limited IPO Incorporated in December 2017, Senores Pharmaceuticals Limited develops and manufactures a range of pharmaceutical products primarily for the regulated markets
Copyright © 2023 - Halalstock.in
You can contribute as little as
100, 200, 500 & so…
every bit counts.
